Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

203.80 USD -0.02 (-0.01%)
Streaming Delayed Price Updated: 11:17 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Swiss biopharma AC Immune has released positive updates this week on both... 
Tags JNJ LLY ACIU
From InvestorPlace
4 Top COVID Stocks to Buy in February
Are you a high-risk stock picker or cautious investor? No matter your answer, there's a stock for you on this list. 
Tags GILD LLY REGN
From Motley Fool
How Risky Are These Heavily Shorted COVID Stocks?
These biotech companies may be among the winners of the coronavirus treatment race -- if all goes well in clinical trials. 
Tags GME Market News VIR
From Motley Fool
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
A huge pivot could reopen doors to growth that seemed closed. 
Tags GILD LLY REGN
From Motley Fool
How IPO Stock AbCellera Biologics Shattered Records On Its Way To Profitability
IPO stock AbCellera Biologics shattered records in June when it began testing of an antibody-based Covid-19 treatment in just 90 days. Now it shows signs of making waves in the stock market 
From Investor's Business Daily
IPO Stock AbCellera Nears Breakout After Lilly-Partnered Covid Drug Nabs OK
Shares of IPO stock AbCellera Biologics rocketed Wednesday after its Eli Lilly-partnered Covid-19 treatment nabbed a Food and Drug Administration second emergency use authorization. 
From Investor's Business Daily
Eli Lilly Doesn't Plan To Claw Back Past Pay From Former CFO - WSJ
According to Wall Street Journal,Eli Lilly And Co’s(NYSE:LLY) said it wouldn’t try toclaw back ... 
Tags Market News News General
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags LABP SQZ SLRX
From Benzinga
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
Eli Lilly’s antibody treatments have received an emergency use authorization from the United States Food and Drug Administration. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Junshi/Lilly Dual Antibody Treatment Approved in US to Treat COVID-19
Junshi Biosciences and Eli Lilly announced their dual mAb treatment was approved in the US to treat COVID-19 under emergency use rules. In a US Phase II/III trial, a combination of Junshi's etesevimab... 
From ChinaBio® Today
A Peek Into The Markets: US Stock Futures Rise; GM, Coca-Cola Earnings In Focus
Pre-open movers U.S. stock futures traded higher in early pre-market trade after closing slightly lower in the previous session. ... 
Tags Pre/Market Outlook Market News GM
From Benzinga
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
Eli Lilly and Co (NYSE: LLY)’s antibody treatments have received an emergency use authorization from the United States Food and ... 
Tags Biotech Antibodies LLY
From Benzinga
What's Behind Incyte's Better-Than-Expected Q4 Earnings
Several products contributed to the biotech's solid growth. 
Tags Market News INCY NVS
From Motley Fool
Eli Lilly's CFO To Step Down Amid Inappropriate Employee Relationship Allegations
Eli Lilly And Co's(NYSE:LLY) Chief Financial OfficerJosh Smiley resignedafter an independent ... 
Tags Market News News General
From Benzinga
Barron's Picks And Pans: Amazon, Biogen, Casey's General Stores, Hilton And More
This weekend's Barron's cover story discusses a coming Alzheimer's crisis. Other featured articles discuss whether ... 
Tags duke realty Market News Hilton Worldwide
From Benzinga
Week In Review: Junshi Signs $1.1 Billion Deal For US-Canada Rights To PD-1
Shanghai Junshi Bio out-licensed US-Canada rights for its anti-PD-1 antibody to Coherus Bio​ in an agreement worth up to $1.1 billion. Syapse closed a $68 million growth equity investment led by... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Week in Review: Junshi Signs $1.1 Billion Deal for US-Canada Rights to PD-1
Deals and Financings   Shanghai Junshi Bio out-licensed US-Canada rights for its PD-1 antibody to Coherus Bio in an agreement worth up to $1.1 billion including $150 million upfront;   Junshi will make... 
From ChinaBio® Today
Pharma ETFs in Focus Post Q4 Earnings
The slew of Q4 results has led to mixed trading in pharma ETFs over the past 10 days. Here is a highlight of those in detail. 
Tags Healthcare ETFs
From Blogs - TalkMarkets
10 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the ... 
Tags General TLRY JNJ
From Benzinga
10 Biggest Price Target Changes For Thursday
SVB Leerink lifted AbbVie Inc (NYSE: ABBV) price target from $128 to $140. AbbVie shares gained 0.7% to $107.65 in pre-market ... 
Tags BIIB Price Target LLY
From Benzinga
1 Major Problem for the Healthcare Industry
One company's obstacle is another company's opportunity. 
Tags Market News CVS MDT
From Motley Fool
Can This Maverick Biotech Become the Frontrunner in the Fight Against Alzheimer's?
Investors are betting this underdog will succeed where even the most reputable of biotech firms have failed. 
Tags LLY MRK BIIB
From Motley Fool
If you want to avoid Alzheimer’s, try doing these things
Why has our understanding of this disease advanced so little? 
Tags LLY BIIB
From MarketWatch
Innovent's PD-1 Approved in China for First-Line NSCLC Indication
Suzhou Innovent Biologics and its partner Eli Lilly announced China approved its supplemental NDA of their partnered anti-PD-1 drug, Tyvyt® (sintilimab injection), as a first-line treatment for... 
From ChinaBio® Today
2 Growth Stocks for In-the-Know Investors
Right now, most investors are oblivious to OptimizeRX and eXp World Holdings. Here's why you should know their names. 
Tags LLY SNY Market News
From Motley Fool
Eli Lilly, Innovent Biologics' Sintilimab Injection Receives China Approval For A Type Of Lung Cancer
Eli Lilly and Company(NYSE:LLY) and its collaborating partnerInnovent Biologics Inc(OTC: IVBXF) has announced ... 
Tags Benzinga Market News IVBXF
From Benzinga
FAANGs' Final Fling: Amazon, Alphabet Wrap Up Earnings Season For "Mega-Caps" Later Today
The big story last week was a dramatic spike involatility. Today, that appears to be unwinding quickly, perhaps lending some ... 
Tags Apple Inc/ LLY United Parcel Service
From Benzinga
Forget Day Trading! Buy and Hold These 2 Stocks
They've consistently beaten the market in recent years and they're still growing. 
Tags FB LLY Market News
From Motley Fool
3 Recent Earnings Stocks Worth Buying Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>These three recent earnings stocks are looking stronger than ever both... 
Tags CVX LLY INTC
From InvestorPlace
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs, And More
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with Novartis AG, Johnson & Johnson, and Eli Lilly And Co all... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.